Skip to main content
CRS 2025 Annual Meeting & Exposition Main banner
Final Program


CRS Abstract Guide

Immuno Delivery
Technical Session

Tech Session VII: Immuno Delivery IV

Friday, July 18, 2025
8:00 AM - 10:00 AM EDT
Location: 120 B/C

    Chair(s)

  • Yuval Shaked, PhD (he/him/his)

    Principal investigator
    Technion, HaZafon, Israel

    • Co-Chair(s)

  • Kuo-Ching Mei, PhD

    Assistant Professor of Molecular Pharmaceutics
    Pharmaceutical Sciences
    Department of Molecular Pharmaceutics, College of Pharmacy, University of Utah
    Salt Lake City, Utah, United States

Targeting immune cells in peripheral tissues and at the sites of immunological reactions, modification of the innate and adaptive immunity, immunomodulation of the tumor microenvironment, and immunotherapy.

Presentations:

  • 8:04 AM - 8:29 AM EDT
    Targeted Nanomedicine Strategies to Reprogram the Tumor Immune Microenviornment

    Invited Speaker: Jai Prakash, PhD (he/him/his) – University of Twente

  • 8:29 AM - 8:54 AM EDT
    Poly(beta aminoester) – extracellular vesicles hybrids for Antitumor Nucleic Acid Vaccination

    Invited Speaker - Exceptional Abstract: Cristina Fornaguera Puigvert, PhD (she/her/hers) – Institut Químic de Sarrià (IQS) - Universitat Ramon Llull (URL)

  • 8:54 AM - 9:05 AM EDT
    Nanoparticles-mediated Inhibition of DPP4 for Improved Cancer Immunochemotherapy

    Oral Abstract Speaker: Shangyu Chen, Postdoctoral Researcher (he/him/his) – University of pittsburgh

  • 9:05 AM - 9:16 AM EDT
    Inhalable Icariin-Loaded Micelle-in-Microparticles Targeted IL-4 Signal Pathway for COPD Treatment

    Oral Abstract Speaker: Chengwei Jiang, PhD (he/him/his) – University College London (UCL)

  • 9:27 AM - 9:38 AM EDT
    Platelet-Drug Conjugates Engineered via One-step Fusion Approach for Cancer Treatment

    Oral Abstract Speaker: Zhengjie Zhao (he/him/his) – Zhejiang University

  • 9:38 AM - 9:49 AM EDT
    Nanoparticle Metalloimmunotherapy for Cancer Eradication: Comprehensive Evaluation From Mice to NHPs

    Oral Abstract Speaker: Kevin Sun – Icahn School of Medicine at Mount Sinai

  • 9:49 AM - 10:00 AM EDT
    Timely administration of drug combination improves chemoimmunotherapy of an immune-cold tumor

    Oral Abstract Speaker: Yanying He – Purdue University